0.03
+0(+0.00%)
Currency In CAD
Address
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
Canada
Phone
204 453 1301
Website
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
First IPO Date
October 01, 2003
| Name | Title | Pay | Year Born |
| Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNC | Interim Chief Executive Officer, Director & Member of Scientific Advisory Board | 113,892 | 1965 |
| Ms. Lori Christofalos | Chief Quality Officer | 249,426 | N/A |
| Mr. Ray Dupuis | Chief Financial Officer | 309,148 | N/A |
| Dr. Gregory S. Schultz Ph.D. | Chief Scientific Officer & Member of Scientific Advisory Board | 0 | 1950 |
| Nicole Sendey | Investor Relations Adviser | 0 | N/A |
| Lorne Gorber | Investor Relations | 0 | N/A |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.